Study on the characteristics and outcomes of patients with intracerebral hemorrhage
A Retrospective Observational Cohort Study in Chinese Patients With Primary Intracerebral Hemorrhage
This study looks at adult patients in China who have had a brain bleed to see what factors affect their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT04803292 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to gather contemporary data on hospitalized adult patients in China who have experienced primary intracerebral hemorrhage (ICH). The research will focus on understanding the prevalence, characteristics, risk factors, treatment approaches, and prognosis associated with ICH. By analyzing existing medical records, the study seeks to provide insights that could inform better management strategies for this serious condition. The findings may help identify cost-effective treatments and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized adults over 18 years old diagnosed with primary intracerebral hemorrhage.
Not a fit: Patients with secondary intracerebral hemorrhage or those who cannot provide complete medical information will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of intracerebral hemorrhage, potentially reducing mortality and enhancing recovery for patients.
How similar studies have performed: While there is limited data on similar observational studies specifically in this demographic, the approach of analyzing cohort data for ICH has been utilized in other contexts with varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized patients over 18 years old of primary intracerebral hemorrhage. Exclusion Criteria: 1. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor 2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients 3. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI 4. patients cannot be followed up for any reasons. 5. patients death in 24 hours 6. pregnant patients 7. surgical evacuation of hematoma
Where this trial is running
Hangzhou, Zhejiang
- 2nd Affiliated Hospital, School of Medicine at Zhejiang University — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Feng Gao, MD,PhD — Second Affiliated Hospital, School of Medicine, Zhejiang University
- Study coordinator: Feng Gao, MD,PhD
- Email: 2202012@zju.edu.cn
- Phone: 13588451471
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.